Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Conferences
Videos
Webinars
Media & Press
Whitepapers
Advertising
Top Story
Antibiotic Resistance
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Researchers are hailing progress toward more rapid detection of antimicrobial resistance (AMR), with a susceptibility test returning results in 30 minutes.
Featured
Regulatory Guidance
FDA issues safety warning for risk of T-cell malignancies with CAR T-cell therapies
Artificial Intelligence
AI model could prevent unnecessary treatment for breast cancer patients, says study
Latest News
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
November 29, 2023
Potential drug target to prevent small vessel disease identified in study
November 29, 2023
Candel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapies
November 28, 2023
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
November 28, 2023
Business Insights
Regulatory Guidance
FDA issues safety warning for risk of T-cell malignancies with CAR T-cell therapies
FDA Clearance
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
Trends and Finance
Candel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapies
Rheumatoid Arthritis
Scipher Medicine, Quest Diagnostics collaborate on RA diagnostics
Diagnostic Technologies
Artificial Intelligence
AI model could prevent unnecessary treatment for breast cancer patients, says study
FDA Clearance
KSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapy
Sequencing
Nanopore sequencing slashes tumor analysis times and costs
Coronary Artery Disease
AI-powered blood test supports risk stratification of heart disease patients
Diseases
Antibiotic Resistance
U.K. researchers use deep learning to develop rapid antimicrobial resistance test
Regulatory Guidance
FDA issues safety warning for risk of T-cell malignancies with CAR T-cell therapies
Artificial Intelligence
AI model could prevent unnecessary treatment for breast cancer patients, says study
Vascular Disease
Potential drug target to prevent small vessel disease identified in study
More from LabPulse.com
Nanopore sequencing slashes tumor analysis times and costs
Nanopore sequencing makes the analysis of copy number variations (CNVs) faster, cheaper, and simpler, according to a preprint paper from researchers at Dartmouth-Hitchcock Medical Center.
November 28, 2023
AI-powered blood test supports risk stratification of heart disease patients
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Nasdaq issues delisting notice to T2 Biosystems
T2 Biosystems has received a delisting notice from Nasdaq after failing to satisfy the minimum $35 million market value of listed securities threshold required to remain listed.
November 27, 2023
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Universal DX partners with Quest Diagnostics, closes $70M series B financing round
Liquid biopsy firm Universal DX and Quest Diagnostics have formed a strategic collaboration under which Quest will exclusively offer services for Universal DX’s Signal-C colorectal cancer screening test in the U.S.
November 21, 2023
Bit.bio unveils cell therapy candidate for liver conditions
Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.
November 22, 2023
AMP, other stakeholders urge Congress to pause FDA LDT rule, update CLIA
The Association for Molecular Pathology (AMP) requested Congress to update the Clinical Laboratory Improvement Amendments (CLIA) as an alternative to the FDA’s proposed rule to increase agency oversight of laboratory-developed tests (LDTs).
November 22, 2023
U.K. regulators approve "world-first" sickle-cell gene therapy
U.K. medical regulators have approved a “world-first” gene therapy that aims to cure two blood disorders: sickle cell disease and transfusion-dependent β-thalassemia. They are the first regulatory body to approve the treatment.
November 20, 2023
AI concurs with humans in heart failure test, suggesting scalable approach to clinical trials
Artificial intelligence (AI) may make clinical trials more efficient by accurately identifying events at scale, a retrospective analysis has found.
November 21, 2023
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
10x Genomics awarded $31M in patent infringement lawsuit against NanoString Technologies
10x Genomics has been awarded more than $31 million in damages by a jury in the U.S. District Court for the District of Delaware in its patent infringement lawsuit against NanoString Technologies.
November 20, 2023
Exact Sciences files patent infringement lawsuit against Geneoscopy
Exact Sciences has filed a patent infringement lawsuit against Geneoscopy alleging that Geneoscopy’s recently launched colorectal screening test infringes on a patented method used in Exact Science’s Cologuard assay.
November 17, 2023
